<table id="id_a109d1ec-f883-47fc-b1e1-d09af7b4d231" width="731.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_58fd9604-8b0e-48be-b253-c2472e299b26">Table 9 Bioavailability of Divalproex Sodium Extended-Release Tablets Relative to Divalproex Sodium Delayed-Release Tablets When Divalproex Sodium Extended-Release Tablets Dose is 8% to 20% Higher</caption>
<col width="20.2%"></col>
<col width="21.1%"></col>
<col width="19.6%"></col>
<col width="19.6%"></col>
<col width="19.6%"></col>
<tbody>
<tr id="id_a9870848-36e9-40bc-bf82-fc32f3ebfc11">
<td align="center" stylecode="Toprule" valign="top">
<content stylecode="bold">Study Population</content>
</td>
<td align="center" stylecode="Toprule" valign="top">
<content stylecode="bold">Regimens</content>
</td>
<td align="center" colspan="3" valign="top">
<content stylecode="bold">Relative Bioavailability</content>
</td>
</tr>
<tr id="id_afd74837-ae44-4d00-a12f-b669e9680387">
<td align="center" stylecode="Botrule" valign="top"></td>
<td align="center" stylecode="Botrule" valign="bottom">
<paragraph>Divalproex Sodium Extended-Release TabletsÂ  vs.<br/>
</paragraph>Divalproex Sodium Delayed-Release Tablets</td>
<td align="center" stylecode="Botrule" valign="bottom">AUC<sub>24</sub>
</td>
<td align="center" stylecode="Botrule" valign="bottom">C<sub>max</sub>
</td>
<td align="center" stylecode="Botrule" valign="bottom">C<sub>min</sub>
</td>
</tr>
<tr id="id_e93cd417-5705-406a-b40c-49a13c3a6dfc">
<td align="center" valign="top">Healthy Volunteers<br/>(n = 35)</td>
<td align="center" valign="top">
<paragraph>1000 mg &amp; 1500 mg<br/>Divalproex Sodium Extended-Release Tablets vs.<br/>875 mg &amp; 1250 mg<br/>
</paragraph>Divalproex Sodium Delayed-Release Tablets</td>
<td align="center" valign="top">1.059</td>
<td align="center" valign="top">0.882</td>
<td align="center" valign="top">1.173</td>
</tr>
<tr id="id_98fdecaf-9214-4b76-81b5-b989dff9029e">
<td align="center" stylecode="Botrule" valign="top">Patients with epilepsy on concomitant enzyme-inducing antiepilepsy drugs<br/>(n = 64)</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>1000 mg to 5000 mg<br/>Divalproex Sodium Extended-Release Tablets vs.<br/>875 mg to 4250 mg<br/>
</paragraph>Divalproex Sodium Delayed-Release Tablets</td>
<td align="center" stylecode="Botrule" valign="top">1.008</td>
<td align="center" stylecode="Botrule" valign="top">0.899</td>
<td align="center" stylecode="Botrule" valign="top">1.022</td>
</tr>
</tbody>
</table>